Paravalvular  ||| S:0 E:13 ||| JJ
leaks ||| S:13 E:18 ||| NNS
:  ||| S:18 E:20 ||| :
mechanisms ||| S:20 E:30 ||| NNS
,  ||| S:30 E:32 ||| ,
diagnosis  ||| S:32 E:42 ||| NN
and  ||| S:42 E:46 ||| CC
management  ||| S:46 E:57 ||| NN
To  ||| S:57 E:60 ||| TO
understand  ||| S:60 E:71 ||| VB
the  ||| S:71 E:75 ||| DT
incidence ||| S:75 E:84 ||| NN
,  ||| S:84 E:86 ||| ,
aetiology  ||| S:86 E:96 ||| NN
and  ||| S:96 E:100 ||| CC
mechanisms  ||| S:100 E:111 ||| NNS
of  ||| S:111 E:114 ||| IN
paravalvular  ||| S:114 E:127 ||| JJ
aortic  ||| S:127 E:134 ||| NN
and  ||| S:134 E:138 ||| CC
mitral  ||| S:138 E:145 ||| JJ
leaks  ||| S:145 E:151 ||| NNS
after  ||| S:151 E:157 ||| IN
valvular  ||| S:157 E:166 ||| JJ
surgery ||| S:166 E:173 ||| NN
;  ||| S:173 E:175 ||| :
reviewing  ||| S:175 E:185 ||| VBG
the  ||| S:185 E:189 ||| DT
best  ||| S:189 E:194 ||| JJS
methods  ||| S:194 E:202 ||| NNS
for  ||| S:202 E:206 ||| IN
diagnosis ||| S:206 E:215 ||| NN
,  ||| S:215 E:217 ||| ,
procedural  ||| S:217 E:228 ||| JJ
guidance  ||| S:228 E:237 ||| NN
and  ||| S:237 E:241 ||| CC
result  ||| S:241 E:248 ||| NN
assessment  ||| S:248 E:259 ||| NN
of  ||| S:259 E:262 ||| IN
these  ||| S:262 E:268 ||| DT
leaks ||| S:268 E:273 ||| NNS
,  ||| S:273 E:275 ||| ,
as  ||| S:275 E:278 ||| RB
well  ||| S:278 E:283 ||| RB
as  ||| S:283 E:286 ||| IN
describing  ||| S:286 E:297 ||| VBG
the  ||| S:297 E:301 ||| DT
different  ||| S:301 E:311 ||| JJ
approaches  ||| S:311 E:322 ||| NNS
to  ||| S:322 E:325 ||| TO
their  ||| S:325 E:331 ||| PRP$
treatment ||| S:331 E:340 ||| NN
.  ||| S:340 E:342 ||| .
A  ||| S:342 E:344 ||| DT
literature  ||| S:344 E:355 ||| NN
search  ||| S:355 E:362 ||| NN
was  ||| S:362 E:366 ||| VBD
undertaken  ||| S:366 E:377 ||| VBN
as  ||| S:377 E:380 ||| IN
well  ||| S:380 E:385 ||| RB
as  ||| S:385 E:388 ||| IN
an  ||| S:388 E:391 ||| DT
in-depth  ||| S:391 E:400 ||| JJ
analysis  ||| S:400 E:409 ||| NN
of  ||| S:409 E:412 ||| IN
our  ||| S:412 E:416 ||| PRP$
own  ||| S:416 E:420 ||| JJ
experience  ||| S:420 E:431 ||| NN
concerning  ||| S:431 E:442 ||| VBG
different  ||| S:442 E:452 ||| JJ
imaging  ||| S:452 E:460 ||| NN
modalities  ||| S:460 E:471 ||| NNS
and  ||| S:471 E:475 ||| CC
various  ||| S:475 E:483 ||| JJ
therapeutic  ||| S:483 E:495 ||| JJ
strategies  ||| S:495 E:506 ||| NNS
for  ||| S:506 E:510 ||| IN
aortic  ||| S:510 E:517 ||| NN
and  ||| S:517 E:521 ||| CC
mitral  ||| S:521 E:528 ||| JJ
paravalvular  ||| S:528 E:541 ||| JJ
leaks ||| S:541 E:546 ||| NNS
.  ||| S:546 E:548 ||| .
The  ||| S:548 E:552 ||| DT
majority  ||| S:552 E:561 ||| NN
of  ||| S:561 E:564 ||| IN
patients  ||| S:564 E:573 ||| NNS
were  ||| S:573 E:578 ||| VBD
diagnosed  ||| S:578 E:588 ||| VBN
using  ||| S:588 E:594 ||| VBG
two-  ||| S:594 E:599 ||| JJ
or  ||| S:599 E:602 ||| CC
three-dimensional  ||| S:602 E:620 ||| JJ
transoesophageal  ||| S:620 E:637 ||| JJ
echocardiography ||| S:637 E:653 ||| NN
,  ||| S:653 E:655 ||| ,
useful  ||| S:655 E:662 ||| JJ
in  ||| S:662 E:665 ||| IN
both  ||| S:665 E:670 ||| DT
guiding  ||| S:670 E:678 ||| VBG
the  ||| S:678 E:682 ||| DT
procedure  ||| S:682 E:692 ||| NN
as  ||| S:692 E:695 ||| IN
well  ||| S:695 E:700 ||| RB
as  ||| S:700 E:703 ||| IN
assessing  ||| S:703 E:713 ||| VBG
the  ||| S:713 E:717 ||| DT
procedural  ||| S:717 E:728 ||| JJ
results ||| S:728 E:735 ||| NNS
.  ||| S:735 E:737 ||| .
Haemoglobin ||| S:737 E:748 ||| NNP
,  ||| S:748 E:750 ||| ,
haematocrit ||| S:750 E:761 ||| NN
,  ||| S:761 E:763 ||| ,
LDH  ||| S:763 E:767 ||| NNP
and  ||| S:767 E:771 ||| CC
haptoglobin  ||| S:771 E:783 ||| JJ
values  ||| S:783 E:790 ||| NNS
were  ||| S:790 E:795 ||| VBD
analysed  ||| S:795 E:804 ||| VBN
to  ||| S:804 E:807 ||| TO
assess  ||| S:807 E:814 ||| VB
haemolysis ||| S:814 E:824 ||| NNS
.  ||| S:824 E:826 ||| .
Procedural  ||| S:826 E:837 ||| JJ
success  ||| S:837 E:845 ||| NN
for  ||| S:845 E:849 ||| IN
percutaneous  ||| S:849 E:862 ||| JJ
closure  ||| S:862 E:870 ||| NN
of  ||| S:870 E:873 ||| IN
paravalvular  ||| S:873 E:886 ||| JJ
aortic  ||| S:886 E:893 ||| JJ
leaks  ||| S:893 E:899 ||| NNS
are  ||| S:899 E:903 ||| VBP
around  ||| S:903 E:910 ||| RB
90 ||| S:910 E:912 ||| CD
%  ||| S:912 E:914 ||| NN
in  ||| S:914 E:917 ||| IN
the  ||| S:917 E:921 ||| DT
different  ||| S:921 E:931 ||| JJ
series ||| S:931 E:937 ||| NN
,  ||| S:937 E:939 ||| ,
with  ||| S:939 E:944 ||| IN
low  ||| S:944 E:948 ||| JJ
complication  ||| S:948 E:961 ||| NN
rates ||| S:961 E:966 ||| NNS
.  ||| S:966 E:968 ||| .
Mitral  ||| S:968 E:975 ||| JJ
leaks  ||| S:975 E:981 ||| NNS
have  ||| S:981 E:986 ||| VBP
been  ||| S:986 E:991 ||| VBN
approached  ||| S:991 E:1002 ||| VBN
by  ||| S:1002 E:1005 ||| IN
transfemoral  ||| S:1005 E:1018 ||| NN
and  ||| S:1018 E:1022 ||| CC
transapical  ||| S:1022 E:1034 ||| JJ
access ||| S:1034 E:1040 ||| NN
;  ||| S:1040 E:1042 ||| :
the  ||| S:1042 E:1046 ||| DT
reported  ||| S:1046 E:1055 ||| JJ
success  ||| S:1055 E:1063 ||| NN
of  ||| S:1063 E:1066 ||| IN
this  ||| S:1066 E:1071 ||| DT
procedure  ||| S:1071 E:1081 ||| NN
ranges  ||| S:1081 E:1088 ||| NNS
from  ||| S:1088 E:1093 ||| IN
75 ||| S:1093 E:1095 ||| CD
%  ||| S:1095 E:1097 ||| NN
to  ||| S:1097 E:1100 ||| TO
more  ||| S:1100 E:1105 ||| JJR
than  ||| S:1105 E:1110 ||| IN
90 ||| S:1110 E:1112 ||| CD
%  ||| S:1112 E:1114 ||| NN
in  ||| S:1114 E:1117 ||| IN
different  ||| S:1117 E:1127 ||| JJ
reports ||| S:1127 E:1134 ||| NNS
.  ||| S:1134 E:1136 ||| .
Complication  ||| S:1136 E:1149 ||| JJ
rates  ||| S:1149 E:1155 ||| NNS
at  ||| S:1155 E:1158 ||| IN
30  ||| S:1158 E:1161 ||| CD
days  ||| S:1161 E:1166 ||| NNS
average  ||| S:1166 E:1174 ||| JJ
10 ||| S:1174 E:1176 ||| CD
%  ||| S:1176 E:1178 ||| NN
and  ||| S:1178 E:1182 ||| CC
mortality  ||| S:1182 E:1192 ||| NN
related  ||| S:1192 E:1200 ||| VBN
to  ||| S:1200 E:1203 ||| TO
the  ||| S:1203 E:1207 ||| DT
procedure  ||| S:1207 E:1217 ||| NN
is  ||| S:1217 E:1220 ||| VBZ
around  ||| S:1220 E:1227 ||| RB
1 ||| S:1227 E:1228 ||| CD
% ||| S:1228 E:1229 ||| NN
.  ||| S:1229 E:1231 ||| .
Late  ||| S:1231 E:1236 ||| RB
follow-up  ||| S:1236 E:1246 ||| JJ
results  ||| S:1246 E:1254 ||| NNS
depend  ||| S:1254 E:1261 ||| VBP
on  ||| S:1261 E:1264 ||| IN
the  ||| S:1264 E:1268 ||| DT
initial  ||| S:1268 E:1276 ||| JJ
anatomy ||| S:1276 E:1283 ||| NN
,  ||| S:1283 E:1285 ||| ,
baseline  ||| S:1285 E:1294 ||| JJ
clinical  ||| S:1294 E:1303 ||| JJ
class  ||| S:1303 E:1309 ||| NN
and  ||| S:1309 E:1313 ||| CC
procedure  ||| S:1313 E:1323 ||| NN
results ||| S:1323 E:1330 ||| NNS
.  ||| S:1330 E:1332 ||| .
Paravalvular  ||| S:1332 E:1345 ||| JJ
leaks  ||| S:1345 E:1351 ||| NNS
after  ||| S:1351 E:1357 ||| IN
surgical  ||| S:1357 E:1366 ||| JJ
valve  ||| S:1366 E:1372 ||| NN
implantation  ||| S:1372 E:1385 ||| NNS
have  ||| S:1385 E:1390 ||| VBP
a  ||| S:1390 E:1392 ||| DT
multifactorial  ||| S:1392 E:1407 ||| JJ
aetiology ||| S:1407 E:1416 ||| NN
,  ||| S:1416 E:1418 ||| ,
but  ||| S:1418 E:1422 ||| CC
are  ||| S:1422 E:1426 ||| VBP
mainly  ||| S:1426 E:1433 ||| RB
related  ||| S:1433 E:1441 ||| VBN
to  ||| S:1441 E:1444 ||| TO
specific  ||| S:1444 E:1453 ||| JJ
anatomic  ||| S:1453 E:1462 ||| JJ
characteristics  ||| S:1462 E:1478 ||| NNS
of  ||| S:1478 E:1481 ||| IN
the  ||| S:1481 E:1485 ||| DT
valvular  ||| S:1485 E:1494 ||| JJ
ring ||| S:1494 E:1498 ||| NN
.  ||| S:1498 E:1500 ||| .
Mitral  ||| S:1500 E:1507 ||| JJ
leaks  ||| S:1507 E:1513 ||| NNS
are  ||| S:1513 E:1517 ||| VBP
three  ||| S:1517 E:1523 ||| CD
times  ||| S:1523 E:1529 ||| NNS
more  ||| S:1529 E:1534 ||| RBR
common  ||| S:1534 E:1541 ||| JJ
than  ||| S:1541 E:1546 ||| IN
aortic  ||| S:1546 E:1553 ||| JJ
leaks  ||| S:1553 E:1559 ||| NNS
and  ||| S:1559 E:1563 ||| CC
the  ||| S:1563 E:1567 ||| DT
incidence  ||| S:1567 E:1577 ||| JJ
increases  ||| S:1577 E:1587 ||| NNS
after  ||| S:1587 E:1593 ||| IN
reoperation ||| S:1593 E:1604 ||| NN
.  ||| S:1604 E:1606 ||| .
Different  ||| S:1606 E:1616 ||| JJ
percutaneous  ||| S:1616 E:1629 ||| JJ
techniques  ||| S:1629 E:1640 ||| NNS
with  ||| S:1640 E:1645 ||| IN
several  ||| S:1645 E:1653 ||| JJ
devices  ||| S:1653 E:1661 ||| NNS
have  ||| S:1661 E:1666 ||| VBP
been  ||| S:1666 E:1671 ||| VBN
explored  ||| S:1671 E:1680 ||| VBN
for  ||| S:1680 E:1684 ||| IN
leak  ||| S:1684 E:1689 ||| JJ
closure ||| S:1689 E:1696 ||| NN
,  ||| S:1696 E:1698 ||| ,
but  ||| S:1698 E:1702 ||| CC
we  ||| S:1702 E:1705 ||| PRP
are  ||| S:1705 E:1709 ||| VBP
still  ||| S:1709 E:1715 ||| RB
lacking  ||| S:1715 E:1723 ||| VBG
devices  ||| S:1723 E:1731 ||| NNS
specifically  ||| S:1731 E:1744 ||| RB
designed  ||| S:1744 E:1753 ||| VBN
to  ||| S:1753 E:1756 ||| TO
treat  ||| S:1756 E:1762 ||| VB
this  ||| S:1762 E:1767 ||| DT
pathology  ||| S:1767 E:1777 ||| NN
more  ||| S:1777 E:1782 ||| RBR
effectively ||| S:1782 E:1793 ||| RB
.  ||| S:1793 E:1795 ||| .
